Skip to main content
Download PDF

Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China

BMC Women's Health volume 23, Article number: 425 (2023) Cite this article

Abstract

Background

TORCH (Toxoplasma gondii [TOX], Cytomegalovirus [CMV], Rubella virus [RV], and Herpes simplex virus [HSV]) represents pathogens known to traverse the maternal-fetal barrier and cause severe neonatal anomalies. We aimed to assess the prevalence of preconception TOX, CMV, and RV infections among women with fertility desire in southern China, and identify related risk factors.

Methods

Data were obtained from a population-based cross-sectional study conducted as part of the National Free Preconception Health Examination Project. Women planning to conceive within the next 6 months in Guangdong Province were enrolled between 2014 and 2019. Information on sociodemographic, gynecological, and obstetric characteristics was collected. Sera were analyzed for TOX IgG, CMV IgG, and RV IgG antibodies using an enzyme-linked immunosorbent assay. Descriptive, univariate, and multivariate logistic regression analyses were performed to assess the association between TORCH infections and related factors.

Results

Among 2,409,137 participants, the prevalence of IgG antibodies for TOX, CMV, and RV was 3.20% (95% CI: 3.18–3.22%), 77.67% (95% CI: 77.62–77.71%) and 76.03% (95% CI: 75.98–76.07%), respectively. Of all participants, 141,047 women (5.85%, 95% CI:5.83–5.88%) reported a history of immunization for RV. Women living in the Pearl River Delta, a more developed region, have significantly lower vaccination rates than those living in other regions. The seropositivity of TOX IgG was highest among women aged 35 years and above, with primary or lower education levels, and rural registration. Factors such as being older, having a higher educational level, and being of other ethnicities were associated with a higher prevalence of naturally acquired CMV and RV infections. Women living in the Pearl River Delta showed a higher risk of TOX, CMV, and RV infections, with aORs of 2.21, 4.45, and 1.76, respectively. A history of pregnancy, gynecological diseases, and sexually transmitted infections were potentially associated with TORCH infections, but this association varied across pathogens.

Conclusion

The findings of this study update the baseline of preconception TORCH infections among women with fertility desire in southern China, helping to estimate the risk of congenital infection and guide the development and implementation of effective prevention measures for preconception TORCH infections.

Peer Review reports

Background

TORCH represents a series of pathogens known to traverse the maternal-fetal barrier and cause adverse pregnancy outcomes and congenital infection in the fetus, conventionally including Toxoplasma gondii (TOX), Cytomegalovirus (CMV), Rubella virus (RV), and Herpes simplex virus (HSV) [1, 2]. Globally, 2–3% of congenital anomalies are attributable to TORCH infections during pregnancy [3]. The annual burden of disability-adjusted life years (DALYs) related to congenital toxoplasmosis is estimated to be 1.20 million DALYs [4]. Approximately 1 million cases of congenital rubella syndrome (CRS) are estimated to occur every year [5], and the case fatality ratio for CRS ranges from 5 to 34%, contributing to approximately 5,000–34,000 annual deaths [6, 7]. Studies have demonstrated that acquiring TORCH infections during the first trimester of gestation is associated with the highest risk of severe neonatal complications [7, 8], necessitating early screening before the critical period of fetal organogenesis [9, 10]. Preconception screening for reproductive-aged women, especially those with a desire for fertility, helps to offer prompt diagnosis and timely treatment decisions for infected women and to carry out prevention measures to reduce primary TORCH infections during pregnancy.

The prevalence of TORCH infections among reproductive-aged women varies dramatically worldwide, with TOX infections ranging from approximately 10% in Switzerland and the United States to over 60% in Iran and Indonesia [11], and CMV infections ranging from less than 50% in Ireland, France, and the United Kingdom to over 90% in Turkey and Korea [12, 13]. In China, one of the most populous countries, the estimated national seroprevalences of TOX, CMV, and RV IgG antibodies in 2010 and 2012 were 2.3% [14], 38.6% [15], and 58.4% [16], respectively. However, the burden of TORCH among women of reproductive age may be underestimated because of the asymptomatic nature of TORCH infections and insufficient screening programs. Prior studies in China have mainly focused on rural residents [17], but the increasing concentration and mobility of the population in urban areas process might facilitate the TORCH transmission among urban residents [18, 19]. Seroepidemiological data on TORCH infections in both rural and urban areas are urgently needed to estimate the infection risk more extensively and precisely. In addition, understanding the potential risk factors for acquiring TORCH infections is important for improving primary prevention strategies. Emerging evidence suggests that the prevalence of TORCH infections may be associated with demographic and clinical characteristics, such as age, ethnicity, educational level, and history of pregnancy [20,21,22], but the significance and directionality of these associations are not consistent [23]. Thus, the factors that influence TORCH infections need to be clarified.

The National Free Preconception Health Examination Project (NFPHEP) conducted in Guangdong Province has provided free preconception screening for TOX, CMV, and RV infections in women desiring fertility in both urban and rural areas. This offered us the opportunity to comprehensively understand the epidemiological profile of TORCH infections in a province with the largest population in southern China (115 million in 2019, including 22.4 million married women) [24] and unevenly distributed medical resources. Therefore, using more than 2.4 million samples derived from the NFPHEP in Guangdong from 2014 to 2019, we determined the prevalence of TOX, CMV, and RV infection among women with fertility desire and explored its influential factors combined with information on sociodemographic, gynecological, and obstetric characteristics. The findings of this study could update the baseline estimates of these infections and guide the development and implementation of effective prevention measures, particularly among vulnerable groups.

Materials and methods

Study design and participants

The NFPHEP is a nationwide population-based cross-sectional survey conducted since 2010 by the Chinese National Health and Family Planning Commission and the Finance Ministry in mainland China. This project provided free preconception care services, including health examinations, risk evaluations, and medical consultations, for married couples planning to conceive within six months. The government of Guangdong province actively responded and expanded the target population to include both rural and urban married couples with the goal of reducing the potential risk of birth defects and improving maternal health. More details about the design, organization, implementation, and quality control of this project have been described previously [25, 26]. Before enrolment, all the participants provided written informed consent. This study was approved by the Institutional Review Board of the Chinese Association of Maternal and Child Health Studies (IRB-201,001).

In this study, we extracted Guangdong data from the NFPHEP database regarding the physical examination and individual basic information of 2,626,851 women of reproductive age (21–49 years) from 2014 to 2019. Participants with incomplete information regarding the serostatus of TOX, CMV, and RV IgG antibodies and duplicate records were excluded from the analysis. Finally, data from 2,409,137 women were used for statistical analyses. A flowchart of the study population selection is shown in Supplementary Fig. 1.

Outcome and variables

Venous blood (5 mL) was collected from each participant and immediately sent to qualified local laboratories, where samples were stored at -30 °C before being tested. Specific IgG antibodies against TOX, CMV, and RV were tested in local laboratories affiliated with medical institutions under qualified quality control mechanisms with available enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s instructions. The reagent kits were approved by the China Food and Drug Administration and selected by local laboratories based on their preference. Infection status was defined based on the results of testing for TOX IgG, CMV IgG, and RV IgG antibodies. Women showing IgG antibody positivity were considered to have latent infections, and those showing IgG antibody negativity were considered susceptible to the pathogen. Participants with suspicious test results and requiring further diagnostic examination were considered negative for IgG antibodies.

Information on sociodemographic characteristics (age, education level, occupation, ethnicity, and household registration), history of pregnancy, gynecological diseases, and sexually transmitted infections (STIs) was collected by a locally trained health worker using a standardized questionnaire. At the same time, the history of RV vaccination was recorded based on the participant’s answer to a “yes or no” question, namely “Have you ever been vaccinated against RV?”. The ages of the women who participated in this study were grouped: 21–24, 25–29, 30–34, 35–39, 40–44, and 45–49 years old. Educational levels were divided into primary school or below, junior high school, senior high school, and college or higher. Occupations were classified as farmers, workers, or other. Ethnicity was grouped into Han and other ethnic groups. The household registration of each participant was classified as rural or urban. In addition, the economy in Guangdong province developed rapidly but unevenly, and the Pearl River Delta region contributed almost 80% of the GDP of the entire province. Thus, the socioeconomic status (SES) of the study participants was measured by residential addresses and divided into living in the Pearl River Delta region (Guangzhou, Foshan, Zhaoqing, Shenzhen, Dongguan, Huizhou, Zhuhai, Zhongshan, and Jiangmen) and non-Pearl River Delta regions (Heyuan, Meizhou, Qingyuan, Shaoguan, Yunfu, Shanwei, Shantou, Chaozhou, Jieyang, Zhanjiang, Yangjiang, and Maoming) (Fig. 1).

Fig. 1
figure 1

Location of Guangdong province in China and the economic geographical division of Guangdong

Full size image

Statistical analysis

These proportions were used to describe participants’ sociodemographic characteristics. The trends and spatial distribution of the prevalence of TOX, CMV, and RV infections from 2014 to 2019 are described. The prevalence of TOX, CMV, and RV IgG antibodies and their 95% confidence intervals (95% CI) were calculated for the entire study group and subpopulations with different individual characteristics. Crude odds ratios (cOR) and adjusted odds ratios (aOR) with 95% CI were calculated using univariate and multivariate logistic regression, respectively, to identify factors associated with the prevalence of TOX, CMV, and RV infections. Statistical significance was defined as a two-sided P value < 0.05. All analyses were performed using R version 4.0.3.

Results

Sociodemographic characteristics and prevalence of TOX, CMV, and CV IgG antibodies

The detailed sociodemographic characteristics of the 2,409,137 women with fertility desires included in this study are shown in Table 1. The median age was 27 years (Interquartile Range: 24–30 years), the majority were of Han ethnicity (95.43%), and had a rural household registration (73.67%). A subgroup of 2,268,090 (94.2%) women who reported no history of RV vaccination was included in the analysis to investigate the association of individual characteristics with RV infection using natural methods. Their characteristics are shown in Supplementary Table 1. Of all participants in this study, the overall seropositivity of TOX, CMV, and RV IgG antibodies among women with fertility desire in Guangdong were 3.20% (95% CI:3.18–3.22%), 77.67% (95% CI:77.62–77.71%), and 76.03% (95% CI:75.98–76.07%), respectively. The annual seropositivity rates of CMV IgG and RV IgG antibodies increased slightly during the study period, whereas that of TOX IgG antibodies remained stable (Fig. 2A). The seropositivity of IgG antibodies varied dramatically across the cities (Fig. 2B-D). The high-prevalence cities were mainly concentrated in the Pearl River Delta region, which has a high population density and relatively high economic development level.

Table 1 Characteristics of 2,409,137 reproductive-aged women preparing for pregnancy, Guangdong, 2014–2019, n (%)
Full size table
Fig. 2
figure 2

The prevalence trend and spatial distribution of TOX, CMV, and RV infections. A) The trend of seropositive rate of IgG antibodies for TOX, CMV, and RV among women with fertility desire in Guangdong from 2014 to 2019. B) The spatial distribution of TOX IgG antibodies. C) The spatial distribution of CMV IgG antibodies. D) The spatial distribution of RV IgG antibodies. The slash part represents the Pearl River Delta region. Abbreviation: TOX: Toxoplasma gondii; CMV: Cytomegalovirus; RV: Rubella virus; IgG: Immunoglobulin G

Full size image

Associations with sociodemographic, gynecological, and obstetric characteristics

Table 2 summarizes the association between sociodemographic, gynecological, and obstetric characteristics and the prevalence of TOX IgG antibodies in both uni- and multivariate models. Compared with women aged 21–24 years, women aged 25–29 and 30–34 years were significantly less likely to be infected with TOX, with aORs (95% CI) of 0.91 (0.89–0.93) and 0.97 (0.95-1.00), respectively. Women aged 35–39, 40–44, and 45–49 years were significantly more likely to be infected, with adjusted ORs (95% CI) as 1.19 (1.15–1.23), 1.39 (1.33–1.46), and 1.49 (1.38–1.62), respectively. When comparing the educational level of primary school or below, women with the educational level of junior high school, senior high school, and college or higher were less likely to be infected with TOX. Urban participants had a significantly lower risk of TOX infection than rural participants (aOR = 0.70, 95% CI:0.69–0.72). Women who were living in the Pearl River Delta region had a higher chance to be infected than those living the non-Pearl River Delta region (aOR = 2.21, 95% CI:2.17–2.25). Women with pregnancy experience had a greater risk of TOX infection compared with those without the experience (aOR = 1.12, 95% CI:1.10–1.14).

Table 2 Association between sociodemographic, gynecological, and obstetric characteristics and the prevalence of TOX IgG antibodies
Full size table

The prevalence of CMV IgG antibodies increased with age (Table 3). Women with an educational level of senior high school or higher had a higher risk of being infected than those with an educational level of primary school or lower. The prevalence of CMV IgG was significantly higher in ethnic minorities than in the Han population (85.69% vs. 77.56%, aOR = 1.44, 95% CI:1.38–1.50). Women who had urban household registration were at higher CMV infection risk than those with rural household registration (85.55% vs. 74.83%, aOR = 1.02, 95% CI:1.01–1.03). In addition, women with a history of pregnancy, gynecological diseases, or STIs had a significantly greater risk (aORs [95% CI]:1.23 [1.22–1.24], 1.23 [1.20–1.26], 1.29 [1.13–1.47], respectively) than those who did not.

Table 3 Association between sociodemographic, gynecological, and obstetric characteristics and the prevalence of CMV IgG antibodies
Full size table

Among the 2,409,137 reproductive-aged women, 141,047 (5.85%, 95% CI:5.83–5.88%) women reported a history of immunization for RV. We then analyzed the prevalence of RV vaccination, stratified by age group and residential region. Women living in cities in the Pearl River Delta region had lower RV vaccination rates than those living in other cities (Fig. 3). The seropositivity of RV IgG antibodies among those having no RV vaccination history was 76.21% (95% CI:76.16–76.26%). In the multivariate logistic regression analysis based on data from those who did not receive the RV vaccination (Table 4), factors such as being elderly, having a higher educational level, being of other ethnicities, living in the Pearl River Delta region, and having a history of gynecological diseases and STIs were all positively associated with the prevalence of naturally acquired RV infection.

Fig. 3
figure 3

Age-specific prevalence of RV vaccination in different residential regions, 2014–2019, Guangdong. *The age group with significant differences in RV vaccination rate between those in the Non-Pearl River Delta region and those in the Pearl River Delta region

Full size image
Table 4 Association between sociodemographic, gynecological, and obstetric characteristics and the prevalence of RV infection in natural ways
Full size table

Discussion

Maternal preconception screening, early recognition, and treatment are key factors in the management of TOX, CMV, and RV infections during pregnancy. Based on the NFPHEP conducted in both rural and urban areas of Guangdong province between 2014 and 2019, this population-based study presents the epidemiological profile and associated influential factors of TOX, CMV, and RV infections acquired naturally. Using more than 2.4 million samples, the findings of this study are useful for reflecting the reality of the preconception of TORCH infections among women with a desire for fertility in Southern China and ascertaining target populations for intervention to reduce congenital infection.

In the present study, the overall prevalence of TOX IgG (3.20%) among women with fertility desire remained relatively low compared to that in other countries such as the United States (9.7–15.0%) [21, 27], Southeast Asia (5.3–39.7%) [28] and Ethiopia (77.7–85.1%) [29]. However, this was higher than that in most other provinces in China, as TOX-IgG seropositivity among reproductive-aged women has previously been reported to be 2.27% in Guangxi [30] and 1.61% in Liaoning [31]. In addition, geographical variation in TOX seropositivity in Guangdong province was observed in this study, and women living in the Pearl River Delta region had a significantly higher risk of TOX infection. This might be explained by the shift in population migration to more developed regions in the quest for job and study opportunities [17], and eating habits shifting to a larger proportion of undercooked seafood and vegetables. Consistent with previous studies [32, 33], we also found the lowest risk of TOX infection among women aged 25–29 years and an increasing infection risk with increasing age. Having a rural household registration and a lower educational level are risk factors for TOX infection, which might result from higher exposure to contaminated soil or water and limited awareness about the disease [34, 35]. Our study also found that women with a history of pregnancy had a higher risk of TOX than non-pregnant women, suggesting that alterations in the immune mechanisms inherent to gestation might make women more vulnerable to this pathogen [22, 36]. At the same time, since approximately 97% of women with a desire for fertility are susceptible to TOX, the need for health education and targeted prevention strategies is underscored to prevent TOX infection during pregnancy.

Unlike TOX, CMV IgG antibodies provide only partial protection [37]. Infants born to mothers with immunity to CMV may acquire congenital CMV infection because of the recurrence of latent infections or reinfection with new strains during pregnancy [38]. Our results showed that the overall seropositivity rate of CMV IgG antibodies among women with fertility desire in Guangdong was 77.67%, which is much higher than the results of a study conducted in 2010–2012 reporting a seropositivity for CMV IgG antibodies of 39.9% among rural women in the same province [15]. This inconsistency implies that comprehensive preconception screening for both urban and rural women is vital to more precisely estimate the prevalence of CMV and identify women with possible infection before pregnancy as much as possible. The higher prevalence of CMV infection among urban women in this study further emphasizes the reproductive health of urban women. The prevalence of CMV IgG increased with age, which is in accordance with previous studies [39, 40] and may be explained by the fact that accumulated exposure during a lifetime leads to an increased probability of infection. The disparity of CMV prevalence between Han people and other ethnicities might be associated with the level of health knowledge and high-risk behavior related to some ethnic customs [41, 42]. Moreover, the CMV infection rate was higher in the Pearl River Delta region than in other regions (89.89% vs. 65.27%; aOR = 4.45, 95% CI:4.41–4.49). This may be explained by the fact that close contact within a population facilitates the transmission of CMV, as the population density in the Pearl River Delta is much higher than that elsewhere in Guangdong. The presence of CMV IgG antibodies is significantly correlated with a history of pregnancy, gynecological diseases, and STIs, emphasizing the important role of sexual transmission in fueling CMV prevalence [43]. Intervention programs targeting spouses, including health education and CMV monitoring, should not be disregarded.

CRS is a frequent cause of birth defects in countries where RV is endemic, and the problem in the Asian region is prominent [44]. It is estimated that there are approximately 5.1 CRS cases per 100,000 live births in China [45]. Maternal immunity to RV before pregnancy protects newborns from CRS [46]; therefore, information on the seropositivity of RV IgG among women who desire fertility helps estimate the immune protection level and CRS risk. Earlier studies in China reported that the seropositivity rates of RV IgG among rural women were 81.0% in Guangdong [16], 78.91% in Hubei [47], and 91.28% in Hainan [48]. This study presented a self-reported RV vaccination rate of 5.85% in Guangdong during 2014–2019, and 76.21% of fertile women desired to acquire RV IgG antibodies by natural infection. Although the measles-mumps-rubella vaccine (MMR) was introduced into the Expanded Programme on Immunization (EPI) by the Chinese government in 2008 [49], the birth cohort we studied was born before the EPI, and no catch-up program for reproductive-aged women was conducted. A large proportion of women are still susceptible to RV infection or develop immunity through natural infection; therefore, continuous attention to the risks associated with RV infection is needed. Consistent with previous reports [50, 51], this study found that women with an educational level of college or higher had the highest RV IgG antibody prevalence. This might be explained by the fact that well-educated women are more likely to contract the virus in various environments and lifestyle patterns as they are often more mobile [52]. Notably, a stratified analysis of residential region revealed that women living in the Pearl River Delta region had significantly lower RV vaccination rates. This might be explained by limited access to public services in such a densely populated environment and the relatively low awareness of healthcare for vulnerable women, such as migrants. Several studies conducted in developed countries have shown that the strategy of catch-up vaccination for older children, adolescents, and reproductive-aged women is beneficial for eliminating congenital rubella [53, 54]. Therefore, continuous screening for RV susceptibility among women with fertility desires and supplementary inoculation of high-risk populations may also be meaningful in China.

This study may be the largest and most recent investigation on the prevalence of preconception TORCH infections in Southern China, with high response rates among women with a desire for fertility in both urban and rural areas. However, the present study had some limitations. First, information on the history of RV vaccination and gynecological and obstetric characteristics was self-reported, which could have led to recall bias. Second, although several sociodemographic, gynecological, and obstetric factors were considered in this study, the association between TOX prevalence and other confounders, such as dietary habits and exposure to cats, was not evaluated. Third, other TORCH pathogens such as HSV, HBV, and syphilis were not included in this study.

In conclusion, the overall prevalence of TOX-IgG among women with a desire for fertility in Southern China remains relatively low, but the absolute number of women infected with TOX and the susceptible population remains large. A large proportion of women (approximately 77%) acquire IgG antibodies against CMV and RV through natural infection. We also observed a relatively low RV vaccination rate, particularly in the Pearl River Delta region. The epidemics of TOX, CMV, and RV infections were significantly more severe in the Pearl River Delta region than in other regions. In addition, demographic (including age, educational level, occupation, and ethnicity), gynecological, and obstetric characteristics were potentially associated with the preconception of TORCH infections, but the association varied across pathogens. Due to the large population density and limited access to health resources per capita, a comprehensive and targeted prevention strategy, including preconception screening, health education, and catch-up immunization, is required to curb further TORCH transmission and reduce the risk of congenital infection.

Data Availability

Data are available upon reasonable request via email to the corresponding author (sysuhanlu@126.com).

References

  1. Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42:77–103.

    PubMed  Google Scholar 

  2. Megli CJ, Coyne CB. Infections at the maternal–fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20:67–82.

    CAS  PubMed  Google Scholar 

  3. Arora N, Sadovsky Y, Dermody TS, Coyne CB. Microbial Vertical transmission during human pregnancy. Cell Host Microbe. 2017;21:561–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.

    PubMed  PubMed Central  Google Scholar 

  5. Rubella vaccines: WHO position paper - July. 2020. https://www.who.int/publications-detail-redirect/WHO-WER9527. Accessed 30 Sep 2022.

  6. Winter AK, Moss WJ, Rubella. The Lancet. 2022;399:1336–46.

    Google Scholar 

  7. Miller E, Cradock-Watson JohnE, Pollock Thomas M. Consequences of confirmed maternal rubella at successive stages of pregnancy. The Lancet. 1982;320:781–4.

    Google Scholar 

  8. Leruez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquemard F, Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin Infect Dis. 2013;56:1428–35.

    CAS  PubMed  Google Scholar 

  9. Kilby MD, Ville Y, Acharya G. Screening for cytomegalovirus infection in pregnancy. BMJ. 2019;:l6507.

  10. Zhang S, Hu L, Chen J, Xu B, Zhou Y-H, Hu Y. Cytomegalovirus seroprevalence in pregnant women and association with adverse Pregnancy/Neonatal outcomes in Jiangsu Province, China. PLoS ONE. 2014;9:e107645.

    PubMed  PubMed Central  Google Scholar 

  11. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385–94.

    PubMed  Google Scholar 

  12. Wang S, Wang T, Zhang W, Liu X, Wang X, Wang H, et al. Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine. 2017;96:e6007.

    PubMed  PubMed Central  Google Scholar 

  13. Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.

    PubMed  Google Scholar 

  14. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Seroepidemiological map of Toxoplasma gondii infection and associated risk factors in preconception period in China: a nationwide cross-sectional study. J Obstet Gynaecol Res. 2018;44:1134–9.

    CAS  PubMed  Google Scholar 

  15. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Seroprevalence of Cytomegalovirus and Associated factors among Preconception Women: a cross-sectional Nationwide Study in China. Front Public Health. 2021;9:631411.

    PubMed  PubMed Central  Google Scholar 

  16. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Rubella virus immunization status in preconception period among chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017;35:3076–81.

    PubMed  Google Scholar 

  17. Qin X, Zhang S, Liu H, Cheng G, Liu Y, Hu M, et al. Seroepidemiology of TORCH infections among 1.7 million women of Childbearing Age in Rural China: a Population-Based cross-sectional study. Am J Trop Med Hyg. 2021;105:1202–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, et al. Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. 2015;15:294.

    PubMed  PubMed Central  Google Scholar 

  19. Mhandire D, Rowland-Jones S, Mhandire K, Kaba M, Dandara C. Epidemiology of Cytomegalovirus among pregnant women in Africa. J Infect Dev Ctries. 2019;13:865–76.

    CAS  PubMed  Google Scholar 

  20. Jiang R-L, Ma L-H, Ma Z-R, Hou G, Zhao Q, Wu X. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China. Microb Pathog. 2018;123:398–401.

    PubMed  Google Scholar 

  21. Jones JL. Toxoplasma gondii infection in the United States: Seroprevalence and Risk factors. Am J Epidemiol. 2001;154:357–65.

    CAS  PubMed  Google Scholar 

  22. Avelino MM, Campos Júnior D, de Parada JB, de Castro AM. Risk factors for Toxoplasma gondii infection in women of childbearing age. Braz J Infect Dis. 2004;8.

  23. Gelaye W, Kebede T, Hailu A. High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41–5.

    PubMed  Google Scholar 

  24. Guangdong Provincial Statistical Information Network. Guangdong Statistical Yearbook 2015-20. http://stats.gd.gov.cn/gdtjnj/index.html. Accessed 25 Dec 2022.

  25. Zhang S, Wang Q, Shen H. Design of the National Free Preconception Health Examination Project in China. Zhonghua Yi Xue Za Zhi. 2015;:162–5.

  26. Wang Q, Zhang M, Zhang S, Hu M, Liu N, Kang X. Establishment of quality assurance system of the National Free Preconception Health Examination Project in China. Zhonghua Yi Xue Za Zhi. 2015;:166–8.

  27. Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, et al. Toxoplasma gondii infection in the United States, 2011–2014. Am J Trop Med Hyg. 2018;98:551–7.

    PubMed  Google Scholar 

  28. Fuchs FE, Pauly M, Black AP, Hübschen JM. Seroprevalence of ToRCH Pathogens in Southeast Asia. Microorganisms. 2021;9:574.

    PubMed  PubMed Central  Google Scholar 

  29. Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M, et al. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect Dis. 2013;13:101.

    PubMed  PubMed Central  Google Scholar 

  30. Lv F, Xie D, Chen M. Analyzed the TORCH screening of free pre-pregnancy health examination of 210 000 people in Guangxi. Chin J Birth Health Heredity. 2014;22:80–2.

    Google Scholar 

  31. Feng, Jin Y, Han W. Analysis of the TORCH detection results among 193490 pre-pregnancy women underwent eugenic health check in Liaoning province. China & Foreign Medical Treatment. 2014;33:55–6.

    Google Scholar 

  32. Robinson E, de Valk H, Villena I, Le Strat Y, Tourdjman M. National perinatal survey demonstrates a decreasing seroprevalence of Toxoplasma gondii infection among pregnant women in France, 1995 to 2016: impact for screening policy. Euro Surveill. 2021;26:1900710.

    PubMed  PubMed Central  Google Scholar 

  33. Cook EAJ, Gitahi N, de Glanville WA, Thomas LF, Kariuki S, Kang’ethe E, et al. Prevalence and risk factors for exposure to Toxoplasma gondii in slaughterhouse workers in western Kenya. BMC Infect Dis. 2021;21:944.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Antinarelli LMR, Silva MR, Guimarães RJ, de PS, Terror MS, Lima PE, Ishii J, de SC, et al. Rural residence remains a risk factor for Toxoplasma infection among pregnant women in a highly urbanized brazilian area: a robust cross-sectional study. Trans R Soc Trop Med Hyg. 2021;115:896–903.

    CAS  PubMed  Google Scholar 

  35. Avelar MV, Martinez VO, de Moura DL, Barros IA, Primo AA da, Duarte S et al. AO,. Association between seroprevalence of IgG anti-Toxoplasma gondii and risk factors for infection among pregnant women in Climério de Oliveira Maternity, Salvador, Bahia, Brazil. Rev Inst Med trop S Paulo. 2017;59.

  36. Costa GB, De Oliveira MC, Gadelha SR, Albuquerque GR, Teixeira M, Raiol MR da. Infectious diseases during pregnancy in Brazil: seroprevalence and risk factors. J Infect Dev Ctries. 2018;12:657–65.

  37. Ju D, Li XZ, Shi YF, Li Y, Guo LQ, Zhang Y. Cytomegalovirus shedding in seropositive healthy women of reproductive age in Tianjin, China. Epidemiol Infect 148:e34.

  38. Mussi-Pinhata MM, Yamamoto AY. Natural history of congenital cytomegalovirus infection in highly seropositive populations. J Infect Dis. 2020;221 Supplement1:15–22.

    Google Scholar 

  39. Qi Y, Zhu S, Li C, Wu H, Yue H, Zhang Y, et al. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China. Eur J Obstet Gynecol Reproductive Biology. 2020;254:114–8.

    CAS  Google Scholar 

  40. Jin Q, Su J, Wu S. Cytomegalovirus infection among pregnant women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions. J Microbiol Biotechnol. 2017;27:1005–9.

    PubMed  Google Scholar 

  41. Meng J, Qin G, Wei Y. Epidemiological analysis on outbreak of Rubella in Middle School in Remote Minority Area. J Med Pest Control. 2010;26:314–6.

    Google Scholar 

  42. Jing W, Yuan Y, Liu M, Ye H, Kong C, Liu J, et al. Ethnic disparities in Hepatitis B virus infection among 1 million Reproductive-Age couples preparing for pregnancy in the rural Yunnan, China: a Population-Based cross-sectional study. Front Med (Lausanne). 2022;8:799873.

    PubMed  Google Scholar 

  43. Lanzieri TM, Kruszon-Moran D, Gambhir M, Bialek SR. Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20–49 years in the USA. Int J Gynaecol Obstet. 2016;135:82–5.

    PubMed  PubMed Central  Google Scholar 

  44. Meng Q, Luo J, Li L, Shi W, Yu J, Shen Y, et al. Rubella seroprevalence among pregnant women in Beijing, China. BMC Infect Dis. 2018;18:130.

    PubMed  PubMed Central  Google Scholar 

  45. Su Q, Feng Z, Hao L, Ma C, Hagan JE, Grant GB, et al. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study. Lancet Infect Dis. 2021;21:1004–13.

    PubMed  PubMed Central  Google Scholar 

  46. Albrecht M, Arck PC. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front Immunol. 2020;11:555.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Li Y, Xu D, Zheng Y, Yan H, Li S, Yi S. Analysis of TORCH infection of 301057 women during prepregnant health examination in Hubei. Mod Prev Med. 2019;46:2384–87.

    Google Scholar 

  48. Xu H, Yu J, Wang Q, Liu H, Wu W. Health examination results of pre-pregnancy eugenics of couples of childbearing age in Hainan, 2017–2018. China Trop Med. 2020;20:56–60.

    Google Scholar 

  49. Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50:353–63.

    PubMed  PubMed Central  Google Scholar 

  50. Fabiani M, Ferrante G, Minardi V, Giambi C, Riccardo F, Declich S, et al. Comparison of rubella immunization rates in immigrant and italian women of childbearing age: results from the italian behavioral surveillance system PASSI (2011–2015). PLoS ONE. 2017;12:e0178122.

    PubMed  PubMed Central  Google Scholar 

  51. Dykewicz CA, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, et al. Rubella seropositivity in the United States, 1988–1994. Clin Infect Dis. 2001;33:1279–86.

    CAS  PubMed  Google Scholar 

  52. Amina M-D, Oladapo S, Habib S, Adebola O, Bimbo K, Daniel A. Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria. Int Health. 2010;2:156–9.

    PubMed  Google Scholar 

  53. Marchi S, Viviani S, Montomoli E, Trombetta CM. Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy. Hum Vaccines Immunotherapeutics. 2020;16:895–8.

    CAS  Google Scholar 

  54. Dontigny L, Arsenault M-Y, Martel M-J. Clinical practice obstetrics committee. Rubella in pregnancy. J Obstet Gynaecol Can. 2008;30:152–8.

    PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank all the community workers, health workers, and participants involved in the NFPHCP for their generous help during the data-gathering process. We express our sincere gratitude to our colleagues whose names do not appear on the paper but who contributed diligently to the research.

Funding

This work was supported by the National Natural Science Foundation of China grants (No. 8210050633), the Natural Science Foundation of Guangdong Province (Nos. 2019A1515011984 and 2020A1515110735), and Guangdong Province Medical Research Funding (Nos. 2022314, 2022326 and B2023416).

Author information

Author notes

  1. Lu Han and Rui Li have contributed equally to this work and share the first authorship.

Authors and Affiliations

  1. NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), 510600, Guangzhou, China

    Lu Han, Yang Hu, Jiabao Wu, Xiaohua Liu, Hua Nie, Weibing Qin & Mingzhen Li

  2. Faculty of Medical Statistics, School of Public Health, Sun Yat-sen University, 510080, Guangzhou, Guangdong, China

    Rui Li, Wenxue Xiong & Li Ling

  3. Clinical research design division, Clinical research center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Li Ling

Authors
  1. Lu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenxue Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiabao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaohua Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hua Nie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Weibing Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Li Ling
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mingzhen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LH, RL, LL, and ML conceived and designed the study. LH, YH, JW, and XL were responsible for data collection and management. LH, RL, and WX cleaned the data, performed the statistical analysis, and drafted the manuscript. HN, WQ, LL, and ML critically revised the manuscript. LH and RL contributed equally. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Li Ling or Mingzhen Li.

Ethics declarations

Competing interests

The authors have no competing interests to declare.

Ethics approval

This study was approval by the Institutional Review Board of the Chinese Association of Maternal and Child Health Studies (IRB-201001). Before enrolment all participants provided a written informed consent. We confirmed that all methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Additional File 1:

Figure and Table

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, L., Li, R., Xiong, W. et al. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China. BMC Women's Health 23, 425 (2023). https://doi.org/10.1186/s12905-023-02560-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-023-02560-4

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us